nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB2—duct of salivary gland—rheumatoid arthritis	0.0666	0.568	CbGeAlD
Lapatinib—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0348	0.0706	CbGbCtD
Lapatinib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0299	0.0606	CbGbCtD
Lapatinib—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0279	0.0566	CbGbCtD
Lapatinib—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0269	0.0545	CbGbCtD
Lapatinib—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0264	0.0535	CbGbCtD
Lapatinib—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0254	0.0514	CbGbCtD
Lapatinib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0243	0.0493	CbGbCtD
Lapatinib—CYP2C19—Prednisone—rheumatoid arthritis	0.0225	0.0455	CbGbCtD
Lapatinib—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0213	0.0431	CbGbCtD
Lapatinib—ABCB1—Betamethasone—rheumatoid arthritis	0.0194	0.0394	CbGbCtD
Lapatinib—ABCB1—Prednisolone—rheumatoid arthritis	0.0192	0.0389	CbGbCtD
Lapatinib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0182	0.0369	CbGbCtD
Lapatinib—ABCB1—Prednisone—rheumatoid arthritis	0.0181	0.0367	CbGbCtD
Lapatinib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0179	0.0363	CbGbCtD
Lapatinib—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0174	0.0352	CbGbCtD
Lapatinib—ABCB1—Cyclosporine—rheumatoid arthritis	0.0172	0.0348	CbGbCtD
Lapatinib—CYP2C8—Dexamethasone—rheumatoid arthritis	0.0167	0.0339	CbGbCtD
Lapatinib—CYP2C19—Dexamethasone—rheumatoid arthritis	0.014	0.0284	CbGbCtD
Lapatinib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0136	0.0275	CbGbCtD
Lapatinib—CYP3A4—Betamethasone—rheumatoid arthritis	0.0117	0.0236	CbGbCtD
Lapatinib—CYP3A4—Prednisolone—rheumatoid arthritis	0.0115	0.0233	CbGbCtD
Lapatinib—ABCB1—Dexamethasone—rheumatoid arthritis	0.0113	0.0229	CbGbCtD
Lapatinib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0109	0.0221	CbGbCtD
Lapatinib—CYP3A4—Prednisone—rheumatoid arthritis	0.0109	0.022	CbGbCtD
Lapatinib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0103	0.0209	CbGbCtD
Lapatinib—ABCB1—Methotrexate—rheumatoid arthritis	0.00909	0.0184	CbGbCtD
Lapatinib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00678	0.0137	CbGbCtD
Lapatinib—ERBB2—exocrine gland—rheumatoid arthritis	0.00592	0.0505	CbGeAlD
Lapatinib—Gefitinib—IRAK1—rheumatoid arthritis	0.0057	0.928	CrCbGaD
Lapatinib—TAP1—parotid gland—rheumatoid arthritis	0.00422	0.036	CbGeAlD
Lapatinib—TAP1—saliva-secreting gland—rheumatoid arthritis	0.00404	0.0345	CbGeAlD
Lapatinib—PIK3C2B—parotid gland—rheumatoid arthritis	0.00397	0.0338	CbGeAlD
Lapatinib—PIK3C2B—saliva-secreting gland—rheumatoid arthritis	0.0038	0.0324	CbGeAlD
Lapatinib—ERBB2—saliva-secreting gland—rheumatoid arthritis	0.00295	0.0252	CbGeAlD
Lapatinib—ERBB4—saliva-secreting gland—rheumatoid arthritis	0.00295	0.0252	CbGeAlD
Lapatinib—PI4KB—parotid gland—rheumatoid arthritis	0.00289	0.0246	CbGeAlD
Lapatinib—PI4KB—saliva-secreting gland—rheumatoid arthritis	0.00277	0.0236	CbGeAlD
Lapatinib—ERBB2—connective tissue—rheumatoid arthritis	0.00271	0.0231	CbGeAlD
Lapatinib—TAP1—tendon—rheumatoid arthritis	0.00255	0.0218	CbGeAlD
Lapatinib—PIK3C2B—tendon—rheumatoid arthritis	0.0024	0.0204	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—rheumatoid arthritis	0.00198	0.0169	CbGeAlD
Lapatinib—ERBB2—digestive system—rheumatoid arthritis	0.00196	0.0167	CbGeAlD
Lapatinib—ERBB4—tendon—rheumatoid arthritis	0.00187	0.0159	CbGeAlD
Lapatinib—PI4KB—tendon—rheumatoid arthritis	0.00175	0.0149	CbGeAlD
Lapatinib—CYP2C19—digestive system—rheumatoid arthritis	0.00061	0.0052	CbGeAlD
Lapatinib—PIK3C2B—Exemestane—Methylprednisolone—rheumatoid arthritis	0.000501	0.077	CbGdCrCtD
Lapatinib—CYP3A5—digestive system—rheumatoid arthritis	0.000481	0.0041	CbGeAlD
Lapatinib—PIK3C2B—Exemestane—Prednisone—rheumatoid arthritis	0.000457	0.0703	CbGdCrCtD
Lapatinib—PIK3C2B—Exemestane—Prednisolone—rheumatoid arthritis	0.000446	0.0686	CbGdCrCtD
Lapatinib—Gefitinib—ALB—rheumatoid arthritis	0.000439	0.0716	CrCbGaD
Lapatinib—ERBB2—Exemestane—Methylprednisolone—rheumatoid arthritis	0.000413	0.0634	CbGdCrCtD
Lapatinib—ERBB2—Exemestane—Prednisone—rheumatoid arthritis	0.000376	0.0579	CbGdCrCtD
Lapatinib—ERBB2—Exemestane—Prednisolone—rheumatoid arthritis	0.000367	0.0565	CbGdCrCtD
Lapatinib—CYP3A4—digestive system—rheumatoid arthritis	0.000361	0.00308	CbGeAlD
Lapatinib—Mental disorder—Hydrocortisone—rheumatoid arthritis	0.000294	0.00188	CcSEcCtD
Lapatinib—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.000292	0.00187	CcSEcCtD
Lapatinib—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.000292	0.00187	CcSEcCtD
Lapatinib—Neutropenia—Prednisone—rheumatoid arthritis	0.000291	0.00187	CcSEcCtD
Lapatinib—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000291	0.00186	CcSEcCtD
Lapatinib—Cough—Cyclosporine—rheumatoid arthritis	0.000287	0.00184	CcSEcCtD
Lapatinib—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000286	0.00183	CcSEcCtD
Lapatinib—Immune system disorder—Methylprednisolone—rheumatoid arthritis	0.000284	0.00182	CcSEcCtD
Lapatinib—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000284	0.00182	CcSEcCtD
Lapatinib—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.000284	0.00182	CcSEcCtD
Lapatinib—Arthralgia—Cyclosporine—rheumatoid arthritis	0.00028	0.00179	CcSEcCtD
Lapatinib—Myalgia—Cyclosporine—rheumatoid arthritis	0.00028	0.00179	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000278	0.00178	CcSEcCtD
Lapatinib—Mental disorder—Methylprednisolone—rheumatoid arthritis	0.000276	0.00177	CcSEcCtD
Lapatinib—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000274	0.00176	CcSEcCtD
Lapatinib—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000274	0.00176	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisone—rheumatoid arthritis	0.000272	0.00175	CcSEcCtD
Lapatinib—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000271	0.00174	CcSEcCtD
Lapatinib—PIK3C2B—Testosterone Propionate—Hydrocortisone—rheumatoid arthritis	0.000269	0.0414	CbGdCrCtD
Lapatinib—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.000268	0.00172	CcSEcCtD
Lapatinib—Infection—Cyclosporine—rheumatoid arthritis	0.000266	0.00171	CcSEcCtD
Lapatinib—Back pain—Triamcinolone—rheumatoid arthritis	0.000266	0.0017	CcSEcCtD
Lapatinib—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000263	0.00168	CcSEcCtD
Lapatinib—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00026	0.00167	CcSEcCtD
Lapatinib—Angiopathy—Dexamethasone—rheumatoid arthritis	0.00026	0.00167	CcSEcCtD
Lapatinib—Angiopathy—Betamethasone—rheumatoid arthritis	0.00026	0.00167	CcSEcCtD
Lapatinib—ABCB1—lymphoid tissue—rheumatoid arthritis	0.000259	0.0022	CbGeAlD
Lapatinib—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000256	0.00164	CcSEcCtD
Lapatinib—Anorexia—Cyclosporine—rheumatoid arthritis	0.000255	0.00164	CcSEcCtD
Lapatinib—ABCB1—digestive system—rheumatoid arthritis	0.000255	0.00218	CbGeAlD
Lapatinib—Alopecia—Dexamethasone—rheumatoid arthritis	0.000253	0.00162	CcSEcCtD
Lapatinib—Alopecia—Betamethasone—rheumatoid arthritis	0.000253	0.00162	CcSEcCtD
Lapatinib—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000252	0.00161	CcSEcCtD
Lapatinib—Asthenia—Leflunomide—rheumatoid arthritis	0.000249	0.0016	CcSEcCtD
Lapatinib—Myalgia—Hydrocortisone—rheumatoid arthritis	0.000248	0.00159	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000247	0.00158	CcSEcCtD
Lapatinib—Pruritus—Leflunomide—rheumatoid arthritis	0.000246	0.00157	CcSEcCtD
Lapatinib—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.000245	0.00157	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000244	0.00156	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.000244	0.00156	CcSEcCtD
Lapatinib—Neutropenia—Methotrexate—rheumatoid arthritis	0.000244	0.00156	CcSEcCtD
Lapatinib—Insomnia—Cyclosporine—rheumatoid arthritis	0.000242	0.00155	CcSEcCtD
Lapatinib—Cough—Triamcinolone—rheumatoid arthritis	0.00024	0.00154	CcSEcCtD
Lapatinib—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000239	0.00153	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Hydrocortisone—rheumatoid arthritis	0.000238	0.0366	CbGdCrCtD
Lapatinib—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.000238	0.00153	CcSEcCtD
Lapatinib—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000238	0.00152	CcSEcCtD
Lapatinib—Infection—Hydrocortisone—rheumatoid arthritis	0.000237	0.00152	CcSEcCtD
Lapatinib—Dyspepsia—Cyclosporine—rheumatoid arthritis	0.000236	0.00151	CcSEcCtD
Lapatinib—Myalgia—Triamcinolone—rheumatoid arthritis	0.000234	0.0015	CcSEcCtD
Lapatinib—Vomiting—Azathioprine—rheumatoid arthritis	0.000234	0.0015	CcSEcCtD
Lapatinib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000234	0.0015	CcSEcCtD
Lapatinib—Pneumonia—Methotrexate—rheumatoid arthritis	0.000234	0.0015	CcSEcCtD
Lapatinib—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000233	0.0015	CcSEcCtD
Lapatinib—Myalgia—Methylprednisolone—rheumatoid arthritis	0.000233	0.0015	CcSEcCtD
Lapatinib—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000233	0.00149	CcSEcCtD
Lapatinib—Infestation—Methotrexate—rheumatoid arthritis	0.000232	0.00149	CcSEcCtD
Lapatinib—Infestation NOS—Methotrexate—rheumatoid arthritis	0.000232	0.00149	CcSEcCtD
Lapatinib—Rash—Azathioprine—rheumatoid arthritis	0.000232	0.00149	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000232	0.00149	CcSEcCtD
Lapatinib—Dermatitis—Azathioprine—rheumatoid arthritis	0.000232	0.00148	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000231	0.00148	CcSEcCtD
Lapatinib—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000231	0.00148	CcSEcCtD
Lapatinib—Fatigue—Cyclosporine—rheumatoid arthritis	0.000231	0.00148	CcSEcCtD
Lapatinib—Headache—Azathioprine—rheumatoid arthritis	0.00023	0.00148	CcSEcCtD
Lapatinib—Constipation—Cyclosporine—rheumatoid arthritis	0.000229	0.00147	CcSEcCtD
Lapatinib—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000227	0.00145	CcSEcCtD
Lapatinib—Stomatitis—Methotrexate—rheumatoid arthritis	0.000226	0.00145	CcSEcCtD
Lapatinib—Angiopathy—Prednisone—rheumatoid arthritis	0.000226	0.00145	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Hydrocortisone—rheumatoid arthritis	0.000226	0.0348	CbGdCrCtD
Lapatinib—Immune system disorder—Prednisone—rheumatoid arthritis	0.000225	0.00144	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Methylprednisolone—rheumatoid arthritis	0.000225	0.0346	CbGdCrCtD
Lapatinib—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000224	0.00144	CcSEcCtD
Lapatinib—PIK3C2B—Danazol—Hydrocortisone—rheumatoid arthritis	0.000224	0.0344	CbGdCrCtD
Lapatinib—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000224	0.00143	CcSEcCtD
Lapatinib—Infection—Triamcinolone—rheumatoid arthritis	0.000223	0.00143	CcSEcCtD
Lapatinib—Infection—Methylprednisolone—rheumatoid arthritis	0.000222	0.00142	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Dexamethasone—rheumatoid arthritis	0.000221	0.034	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Betamethasone—rheumatoid arthritis	0.000221	0.034	CbGdCrCtD
Lapatinib—Vomiting—Leflunomide—rheumatoid arthritis	0.000221	0.00141	CcSEcCtD
Lapatinib—Insomnia—Prednisolone—rheumatoid arthritis	0.000221	0.00141	CcSEcCtD
Lapatinib—Alopecia—Prednisone—rheumatoid arthritis	0.00022	0.00141	CcSEcCtD
Lapatinib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.00022	0.00141	CcSEcCtD
Lapatinib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000219	0.00141	CcSEcCtD
Lapatinib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000219	0.0014	CcSEcCtD
Lapatinib—Epistaxis—Methotrexate—rheumatoid arthritis	0.000219	0.0014	CcSEcCtD
Lapatinib—Rash—Leflunomide—rheumatoid arthritis	0.000219	0.0014	CcSEcCtD
Lapatinib—Dermatitis—Leflunomide—rheumatoid arthritis	0.000219	0.0014	CcSEcCtD
Lapatinib—Mental disorder—Prednisone—rheumatoid arthritis	0.000219	0.0014	CcSEcCtD
Lapatinib—Nausea—Azathioprine—rheumatoid arthritis	0.000218	0.0014	CcSEcCtD
Lapatinib—Headache—Leflunomide—rheumatoid arthritis	0.000218	0.00139	CcSEcCtD
Lapatinib—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000217	0.00139	CcSEcCtD
Lapatinib—Malnutrition—Prednisone—rheumatoid arthritis	0.000217	0.00139	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000217	0.00139	CcSEcCtD
Lapatinib—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000215	0.00138	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Methylprednisolone—rheumatoid arthritis	0.000213	0.0328	CbGdCrCtD
Lapatinib—Myalgia—Dexamethasone—rheumatoid arthritis	0.000212	0.00136	CcSEcCtD
Lapatinib—Myalgia—Betamethasone—rheumatoid arthritis	0.000212	0.00136	CcSEcCtD
Lapatinib—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000212	0.00136	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Dexamethasone—rheumatoid arthritis	0.00021	0.0323	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Betamethasone—rheumatoid arthritis	0.00021	0.0323	CbGdCrCtD
Lapatinib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.00021	0.00134	CcSEcCtD
Lapatinib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000207	0.00133	CcSEcCtD
Lapatinib—Nausea—Leflunomide—rheumatoid arthritis	0.000206	0.00132	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000206	0.00132	CcSEcCtD
Lapatinib—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000205	0.00132	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Triamcinolone—rheumatoid arthritis	0.000205	0.0316	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Prednisone—rheumatoid arthritis	0.000205	0.0315	CbGdCrCtD
Lapatinib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000204	0.00131	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000204	0.00131	CcSEcCtD
Lapatinib—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000203	0.0013	CcSEcCtD
Lapatinib—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000203	0.0013	CcSEcCtD
Lapatinib—Insomnia—Triamcinolone—rheumatoid arthritis	0.000203	0.0013	CcSEcCtD
Lapatinib—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000202	0.0013	CcSEcCtD
Lapatinib—Infection—Dexamethasone—rheumatoid arthritis	0.000202	0.0013	CcSEcCtD
Lapatinib—Infection—Betamethasone—rheumatoid arthritis	0.000202	0.0013	CcSEcCtD
Lapatinib—PIK3C2B—Norethindrone—Hydrocortisone—rheumatoid arthritis	0.000202	0.031	CbGdCrCtD
Lapatinib—Anaemia—Prednisone—rheumatoid arthritis	0.000201	0.00129	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Prednisolone—rheumatoid arthritis	0.0002	0.0308	CbGdCrCtD
Lapatinib—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.0002	0.00128	CcSEcCtD
Lapatinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.0002	0.00128	CcSEcCtD
Lapatinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.0002	0.00128	CcSEcCtD
Lapatinib—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000197	0.00127	CcSEcCtD
Lapatinib—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000197	0.00127	CcSEcCtD
Lapatinib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000197	0.00126	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisone—rheumatoid arthritis	0.000195	0.03	CbGdCrCtD
Lapatinib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000195	0.00125	CcSEcCtD
Lapatinib—Anorexia—Dexamethasone—rheumatoid arthritis	0.000194	0.00124	CcSEcCtD
Lapatinib—Anorexia—Betamethasone—rheumatoid arthritis	0.000194	0.00124	CcSEcCtD
Lapatinib—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000193	0.00124	CcSEcCtD
Lapatinib—Fatigue—Triamcinolone—rheumatoid arthritis	0.000193	0.00124	CcSEcCtD
Lapatinib—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000193	0.00124	CcSEcCtD
Lapatinib—PIK3C2B—Danazol—Prednisone—rheumatoid arthritis	0.000193	0.0297	CbGdCrCtD
Lapatinib—Asthenia—Cyclosporine—rheumatoid arthritis	0.000192	0.00123	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisolone—rheumatoid arthritis	0.00019	0.0292	CbGdCrCtD
Lapatinib—Pruritus—Cyclosporine—rheumatoid arthritis	0.00019	0.00122	CcSEcCtD
Lapatinib—Angiopathy—Methotrexate—rheumatoid arthritis	0.000189	0.00121	CcSEcCtD
Lapatinib—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000188	0.00121	CcSEcCtD
Lapatinib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000188	0.00121	CcSEcCtD
Lapatinib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000188	0.0012	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000185	0.00119	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000185	0.00119	CcSEcCtD
Lapatinib—Myalgia—Prednisone—rheumatoid arthritis	0.000185	0.00118	CcSEcCtD
Lapatinib—Arthralgia—Prednisone—rheumatoid arthritis	0.000185	0.00118	CcSEcCtD
Lapatinib—Alopecia—Methotrexate—rheumatoid arthritis	0.000184	0.00118	CcSEcCtD
Lapatinib—Insomnia—Dexamethasone—rheumatoid arthritis	0.000184	0.00118	CcSEcCtD
Lapatinib—Insomnia—Betamethasone—rheumatoid arthritis	0.000184	0.00118	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000184	0.00118	CcSEcCtD
Lapatinib—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000183	0.00118	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000183	0.00117	CcSEcCtD
Lapatinib—Mental disorder—Methotrexate—rheumatoid arthritis	0.000183	0.00117	CcSEcCtD
Lapatinib—Malnutrition—Methotrexate—rheumatoid arthritis	0.000181	0.00116	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00018	0.00115	CcSEcCtD
Lapatinib—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000179	0.00115	CcSEcCtD
Lapatinib—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000179	0.00115	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000177	0.00114	CcSEcCtD
Lapatinib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000177	0.00113	CcSEcCtD
Lapatinib—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000177	0.00113	CcSEcCtD
Lapatinib—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000177	0.00113	CcSEcCtD
Lapatinib—Infection—Prednisone—rheumatoid arthritis	0.000176	0.00113	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000176	0.00113	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000176	0.00113	CcSEcCtD
Lapatinib—Back pain—Methotrexate—rheumatoid arthritis	0.000176	0.00112	CcSEcCtD
Lapatinib—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000175	0.00112	CcSEcCtD
Lapatinib—Fatigue—Dexamethasone—rheumatoid arthritis	0.000175	0.00112	CcSEcCtD
Lapatinib—Fatigue—Betamethasone—rheumatoid arthritis	0.000175	0.00112	CcSEcCtD
Lapatinib—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000174	0.00111	CcSEcCtD
Lapatinib—Skin disorder—Prednisone—rheumatoid arthritis	0.000172	0.0011	CcSEcCtD
Lapatinib—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000171	0.0011	CcSEcCtD
Lapatinib—Vomiting—Cyclosporine—rheumatoid arthritis	0.00017	0.00109	CcSEcCtD
Lapatinib—Rash—Cyclosporine—rheumatoid arthritis	0.000169	0.00108	CcSEcCtD
Lapatinib—Anorexia—Prednisone—rheumatoid arthritis	0.000169	0.00108	CcSEcCtD
Lapatinib—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000169	0.00108	CcSEcCtD
Lapatinib—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000168	0.00108	CcSEcCtD
Lapatinib—Headache—Cyclosporine—rheumatoid arthritis	0.000168	0.00108	CcSEcCtD
Lapatinib—Anaemia—Methotrexate—rheumatoid arthritis	0.000168	0.00107	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000166	0.00107	CcSEcCtD
Lapatinib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000166	0.00107	CcSEcCtD
Lapatinib—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000165	0.00106	CcSEcCtD
Lapatinib—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000165	0.00106	CcSEcCtD
Lapatinib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000163	0.00104	CcSEcCtD
Lapatinib—Leukopenia—Methotrexate—rheumatoid arthritis	0.000162	0.00104	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000161	0.00103	CcSEcCtD
Lapatinib—Asthenia—Triamcinolone—rheumatoid arthritis	0.000161	0.00103	CcSEcCtD
Lapatinib—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000161	0.00103	CcSEcCtD
Lapatinib—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000161	0.00103	CcSEcCtD
Lapatinib—PIK3C2B—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000161	0.0247	CbGdCrCtD
Lapatinib—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000161	0.00103	CcSEcCtD
Lapatinib—Insomnia—Prednisone—rheumatoid arthritis	0.00016	0.00103	CcSEcCtD
Lapatinib—Nausea—Cyclosporine—rheumatoid arthritis	0.000159	0.00102	CcSEcCtD
Lapatinib—Pruritus—Triamcinolone—rheumatoid arthritis	0.000159	0.00102	CcSEcCtD
Lapatinib—Cough—Methotrexate—rheumatoid arthritis	0.000158	0.00101	CcSEcCtD
Lapatinib—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000158	0.00101	CcSEcCtD
Lapatinib—Dyspepsia—Prednisone—rheumatoid arthritis	0.000156	0.001	CcSEcCtD
Lapatinib—Arthralgia—Methotrexate—rheumatoid arthritis	0.000154	0.00099	CcSEcCtD
Lapatinib—Myalgia—Methotrexate—rheumatoid arthritis	0.000154	0.00099	CcSEcCtD
Lapatinib—Decreased appetite—Prednisone—rheumatoid arthritis	0.000154	0.000987	CcSEcCtD
Lapatinib—Rash—Prednisolone—rheumatoid arthritis	0.000154	0.000985	CcSEcCtD
Lapatinib—Dermatitis—Prednisolone—rheumatoid arthritis	0.000154	0.000985	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000153	0.000983	CcSEcCtD
Lapatinib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000153	0.000981	CcSEcCtD
Lapatinib—Fatigue—Prednisone—rheumatoid arthritis	0.000153	0.000979	CcSEcCtD
Lapatinib—Headache—Prednisolone—rheumatoid arthritis	0.000153	0.000979	CcSEcCtD
Lapatinib—Constipation—Prednisone—rheumatoid arthritis	0.000152	0.000971	CcSEcCtD
Lapatinib—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000151	0.000971	CcSEcCtD
Lapatinib—Rash—Hydrocortisone—rheumatoid arthritis	0.00015	0.000962	CcSEcCtD
Lapatinib—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.00015	0.000962	CcSEcCtD
Lapatinib—Headache—Hydrocortisone—rheumatoid arthritis	0.000149	0.000956	CcSEcCtD
Lapatinib—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000148	0.000949	CcSEcCtD
Lapatinib—Infection—Methotrexate—rheumatoid arthritis	0.000147	0.000943	CcSEcCtD
Lapatinib—Asthenia—Dexamethasone—rheumatoid arthritis	0.000146	0.000936	CcSEcCtD
Lapatinib—Asthenia—Betamethasone—rheumatoid arthritis	0.000146	0.000936	CcSEcCtD
Lapatinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000145	0.000931	CcSEcCtD
Lapatinib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000145	0.000929	CcSEcCtD
Lapatinib—Nausea—Prednisolone—rheumatoid arthritis	0.000145	0.000928	CcSEcCtD
Lapatinib—Pruritus—Betamethasone—rheumatoid arthritis	0.000144	0.000923	CcSEcCtD
Lapatinib—Pruritus—Dexamethasone—rheumatoid arthritis	0.000144	0.000923	CcSEcCtD
Lapatinib—Skin disorder—Methotrexate—rheumatoid arthritis	0.000144	0.000922	CcSEcCtD
Lapatinib—Vomiting—Triamcinolone—rheumatoid arthritis	0.000143	0.000914	CcSEcCtD
Lapatinib—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000142	0.000912	CcSEcCtD
Lapatinib—Nausea—Hydrocortisone—rheumatoid arthritis	0.000141	0.000907	CcSEcCtD
Lapatinib—Rash—Triamcinolone—rheumatoid arthritis	0.000141	0.000906	CcSEcCtD
Lapatinib—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000141	0.000905	CcSEcCtD
Lapatinib—Anorexia—Methotrexate—rheumatoid arthritis	0.000141	0.000905	CcSEcCtD
Lapatinib—Rash—Methylprednisolone—rheumatoid arthritis	0.000141	0.000904	CcSEcCtD
Lapatinib—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000141	0.000903	CcSEcCtD
Lapatinib—Headache—Triamcinolone—rheumatoid arthritis	0.00014	0.0009	CcSEcCtD
Lapatinib—Headache—Methylprednisolone—rheumatoid arthritis	0.00014	0.000898	CcSEcCtD
Lapatinib—Abdominal pain—Prednisone—rheumatoid arthritis	0.00014	0.000898	CcSEcCtD
Lapatinib—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000139	0.000892	CcSEcCtD
Lapatinib—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000139	0.000892	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000135	0.000865	CcSEcCtD
Lapatinib—Insomnia—Methotrexate—rheumatoid arthritis	0.000134	0.000858	CcSEcCtD
Lapatinib—Nausea—Triamcinolone—rheumatoid arthritis	0.000133	0.000854	CcSEcCtD
Lapatinib—Nausea—Methylprednisolone—rheumatoid arthritis	0.000133	0.000852	CcSEcCtD
Lapatinib—ERBB2—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000132	0.0203	CbGdCrCtD
Lapatinib—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000132	0.000846	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000131	0.000837	CcSEcCtD
Lapatinib—Dyspepsia—Methotrexate—rheumatoid arthritis	0.00013	0.000835	CcSEcCtD
Lapatinib—Vomiting—Betamethasone—rheumatoid arthritis	0.000129	0.000829	CcSEcCtD
Lapatinib—Vomiting—Dexamethasone—rheumatoid arthritis	0.000129	0.000829	CcSEcCtD
Lapatinib—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000129	0.000825	CcSEcCtD
Lapatinib—Rash—Dexamethasone—rheumatoid arthritis	0.000128	0.000822	CcSEcCtD
Lapatinib—Rash—Betamethasone—rheumatoid arthritis	0.000128	0.000822	CcSEcCtD
Lapatinib—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000128	0.000822	CcSEcCtD
Lapatinib—Dermatitis—Betamethasone—rheumatoid arthritis	0.000128	0.000822	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000128	0.000819	CcSEcCtD
Lapatinib—Fatigue—Methotrexate—rheumatoid arthritis	0.000128	0.000818	CcSEcCtD
Lapatinib—Headache—Dexamethasone—rheumatoid arthritis	0.000127	0.000817	CcSEcCtD
Lapatinib—Headache—Betamethasone—rheumatoid arthritis	0.000127	0.000817	CcSEcCtD
Lapatinib—Asthenia—Prednisone—rheumatoid arthritis	0.000127	0.000815	CcSEcCtD
Lapatinib—Pruritus—Prednisone—rheumatoid arthritis	0.000125	0.000804	CcSEcCtD
Lapatinib—Diarrhoea—Prednisone—rheumatoid arthritis	0.000121	0.000777	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000121	0.000776	CcSEcCtD
Lapatinib—Nausea—Betamethasone—rheumatoid arthritis	0.000121	0.000775	CcSEcCtD
Lapatinib—Nausea—Dexamethasone—rheumatoid arthritis	0.000121	0.000775	CcSEcCtD
Lapatinib—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000117	0.00075	CcSEcCtD
Lapatinib—Vomiting—Prednisone—rheumatoid arthritis	0.000113	0.000722	CcSEcCtD
Lapatinib—Rash—Prednisone—rheumatoid arthritis	0.000112	0.000716	CcSEcCtD
Lapatinib—Dermatitis—Prednisone—rheumatoid arthritis	0.000112	0.000715	CcSEcCtD
Lapatinib—Headache—Prednisone—rheumatoid arthritis	0.000111	0.000711	CcSEcCtD
Lapatinib—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000109	0.000699	CcSEcCtD
Lapatinib—Asthenia—Methotrexate—rheumatoid arthritis	0.000106	0.000681	CcSEcCtD
Lapatinib—Nausea—Prednisone—rheumatoid arthritis	0.000105	0.000675	CcSEcCtD
Lapatinib—Pruritus—Methotrexate—rheumatoid arthritis	0.000105	0.000672	CcSEcCtD
Lapatinib—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000101	0.000649	CcSEcCtD
Lapatinib—Vomiting—Methotrexate—rheumatoid arthritis	9.42e-05	0.000603	CcSEcCtD
Lapatinib—Rash—Methotrexate—rheumatoid arthritis	9.34e-05	0.000598	CcSEcCtD
Lapatinib—Dermatitis—Methotrexate—rheumatoid arthritis	9.33e-05	0.000598	CcSEcCtD
Lapatinib—Headache—Methotrexate—rheumatoid arthritis	9.28e-05	0.000595	CcSEcCtD
Lapatinib—Nausea—Methotrexate—rheumatoid arthritis	8.8e-05	0.000564	CcSEcCtD
Lapatinib—EGFR—Disease—PRKCQ—rheumatoid arthritis	1.56e-05	7.09e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LEP—rheumatoid arthritis	1.55e-05	7.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL5—rheumatoid arthritis	1.55e-05	7.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR6—rheumatoid arthritis	1.54e-05	6.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT1—rheumatoid arthritis	1.54e-05	6.96e-05	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—rheumatoid arthritis	1.53e-05	6.95e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—rheumatoid arthritis	1.53e-05	6.92e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—rheumatoid arthritis	1.53e-05	6.92e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LEP—rheumatoid arthritis	1.52e-05	6.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CSF2—rheumatoid arthritis	1.52e-05	6.9e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—rheumatoid arthritis	1.52e-05	6.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TYK2—rheumatoid arthritis	1.52e-05	6.87e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—rheumatoid arthritis	1.51e-05	6.86e-05	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—rheumatoid arthritis	1.51e-05	6.85e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—rheumatoid arthritis	1.5e-05	6.81e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—rheumatoid arthritis	1.5e-05	6.81e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	1.5e-05	6.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NCF2—rheumatoid arthritis	1.5e-05	6.8e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—rheumatoid arthritis	1.5e-05	6.79e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—rheumatoid arthritis	1.49e-05	6.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQB1—rheumatoid arthritis	1.49e-05	6.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MED1—rheumatoid arthritis	1.48e-05	6.69e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLB1—rheumatoid arthritis	1.47e-05	6.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SH2B3—rheumatoid arthritis	1.46e-05	6.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TRAF6—rheumatoid arthritis	1.46e-05	6.63e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FN1—rheumatoid arthritis	1.46e-05	6.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GZMB—rheumatoid arthritis	1.45e-05	6.59e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.45e-05	6.59e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.44e-05	6.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PTK2—rheumatoid arthritis	1.44e-05	6.53e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FN1—rheumatoid arthritis	1.44e-05	6.52e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6ST—rheumatoid arthritis	1.43e-05	6.49e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—BGN—rheumatoid arthritis	1.43e-05	6.47e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NFKB1—rheumatoid arthritis	1.42e-05	6.45e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.42e-05	6.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1A—rheumatoid arthritis	1.41e-05	6.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL18—rheumatoid arthritis	1.41e-05	6.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL3—rheumatoid arthritis	1.41e-05	6.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL2—rheumatoid arthritis	1.41e-05	6.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40LG—rheumatoid arthritis	1.41e-05	6.38e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NFKB1—rheumatoid arthritis	1.4e-05	6.36e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MAPK8—rheumatoid arthritis	1.4e-05	6.34e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CD80—rheumatoid arthritis	1.4e-05	6.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.4e-05	6.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCR5—rheumatoid arthritis	1.39e-05	6.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CSF2—rheumatoid arthritis	1.39e-05	6.3e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—rheumatoid arthritis	1.39e-05	6.3e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SAA1—rheumatoid arthritis	1.38e-05	6.26e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MAPK8—rheumatoid arthritis	1.38e-05	6.25e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CD80—rheumatoid arthritis	1.38e-05	6.25e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ACP5—rheumatoid arthritis	1.37e-05	6.22e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—B3GNT2—rheumatoid arthritis	1.37e-05	6.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2RA—rheumatoid arthritis	1.37e-05	6.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—rheumatoid arthritis	1.37e-05	6.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—C3—rheumatoid arthritis	1.36e-05	6.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AGER—rheumatoid arthritis	1.36e-05	6.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—rheumatoid arthritis	1.35e-05	6.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NCF1—rheumatoid arthritis	1.35e-05	6.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NFKB1—rheumatoid arthritis	1.34e-05	6.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-B—rheumatoid arthritis	1.34e-05	6.06e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—POMC—rheumatoid arthritis	1.33e-05	6.03e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MED1—rheumatoid arthritis	1.32e-05	5.97e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—rheumatoid arthritis	1.32e-05	5.97e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	1.31e-05	5.95e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.31e-05	5.94e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—POMC—rheumatoid arthritis	1.31e-05	5.94e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCL2—rheumatoid arthritis	1.3e-05	5.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—rheumatoid arthritis	1.3e-05	5.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CD28—rheumatoid arthritis	1.3e-05	5.89e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6R—rheumatoid arthritis	1.3e-05	5.88e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MED1—rheumatoid arthritis	1.29e-05	5.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCL2—rheumatoid arthritis	1.28e-05	5.81e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6R—rheumatoid arthritis	1.28e-05	5.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2RA—rheumatoid arthritis	1.25e-05	5.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—C3—rheumatoid arthritis	1.24e-05	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-A—rheumatoid arthritis	1.24e-05	5.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—BGN—rheumatoid arthritis	1.24e-05	5.6e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	1.22e-05	5.55e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	1.22e-05	5.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.22e-05	5.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—rheumatoid arthritis	1.21e-05	5.5e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.2e-05	5.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL12—rheumatoid arthritis	1.2e-05	5.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.2e-05	5.44e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	1.2e-05	5.42e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ACP5—rheumatoid arthritis	1.2e-05	5.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6ST—rheumatoid arthritis	1.19e-05	5.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.19e-05	5.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—rheumatoid arthritis	1.18e-05	5.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NFKB1—rheumatoid arthritis	1.18e-05	5.36e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TYK2—rheumatoid arthritis	1.18e-05	5.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—rheumatoid arthritis	1.18e-05	5.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CCR5—rheumatoid arthritis	1.17e-05	5.32e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TYK2—rheumatoid arthritis	1.16e-05	5.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MAPK8—rheumatoid arthritis	1.16e-05	5.27e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOS3—rheumatoid arthritis	1.16e-05	5.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—rheumatoid arthritis	1.15e-05	5.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HLA-A—rheumatoid arthritis	1.14e-05	5.19e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOS3—rheumatoid arthritis	1.14e-05	5.18e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALOX5—rheumatoid arthritis	1.14e-05	5.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NFKB1—rheumatoid arthritis	1.13e-05	5.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR4—rheumatoid arthritis	1.13e-05	5.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DRB1—rheumatoid arthritis	1.13e-05	5.13e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.12e-05	5.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.12e-05	5.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SYK—rheumatoid arthritis	1.12e-05	5.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—rheumatoid arthritis	1.11e-05	5.05e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—BGN—rheumatoid arthritis	1.1e-05	5e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.1e-05	4.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.1e-05	4.96e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—rheumatoid arthritis	1.09e-05	4.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—POMC—rheumatoid arthritis	1.09e-05	4.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ICAM1—rheumatoid arthritis	1.09e-05	4.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6ST—rheumatoid arthritis	1.09e-05	4.93e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—rheumatoid arthritis	1.08e-05	4.89e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—BGN—rheumatoid arthritis	1.08e-05	4.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT1—rheumatoid arthritis	1.08e-05	4.88e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	1.07e-05	4.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL2—rheumatoid arthritis	1.06e-05	4.83e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.06e-05	4.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6R—rheumatoid arthritis	1.06e-05	4.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL10—rheumatoid arthritis	1.06e-05	4.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD80—rheumatoid arthritis	1.05e-05	4.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—rheumatoid arthritis	1.04e-05	4.72e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.03e-05	4.66e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	1.01e-05	4.6e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL8—rheumatoid arthritis	1.01e-05	4.59e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6ST—rheumatoid arthritis	1e-05	4.55e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1e-05	4.53e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	9.99e-06	4.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—rheumatoid arthritis	9.96e-06	4.51e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	9.91e-06	4.49e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	9.9e-06	4.49e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—rheumatoid arthritis	9.83e-06	4.46e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	9.72e-06	4.41e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GC—rheumatoid arthritis	9.72e-06	4.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6R—rheumatoid arthritis	9.7e-06	4.4e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—rheumatoid arthritis	9.68e-06	4.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP3—rheumatoid arthritis	9.67e-06	4.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TYK2—rheumatoid arthritis	9.67e-06	4.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD80—rheumatoid arthritis	9.66e-06	4.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTK2—rheumatoid arthritis	9.31e-06	4.22e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—rheumatoid arthritis	9.3e-06	4.22e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	9.27e-06	4.2e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NFKB1—rheumatoid arthritis	9.2e-06	4.17e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—rheumatoid arthritis	9.16e-06	4.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL5—rheumatoid arthritis	9.13e-06	4.14e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	9.12e-06	4.13e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NFKB1—rheumatoid arthritis	9.07e-06	4.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK8—rheumatoid arthritis	9.05e-06	4.1e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	9.04e-06	4.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CSF2—rheumatoid arthritis	8.99e-06	4.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6R—rheumatoid arthritis	8.95e-06	4.06e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—rheumatoid arthritis	8.94e-06	4.05e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.93e-06	4.05e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK8—rheumatoid arthritis	8.91e-06	4.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TYK2—rheumatoid arthritis	8.83e-06	4e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—rheumatoid arthritis	8.8e-06	3.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SPP1—rheumatoid arthritis	8.45e-06	3.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.42e-06	3.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—rheumatoid arthritis	8.4e-06	3.81e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—rheumatoid arthritis	8.35e-06	3.79e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	8.27e-06	3.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—rheumatoid arthritis	8.27e-06	3.75e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—rheumatoid arthritis	8.25e-06	3.74e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—rheumatoid arthritis	8.23e-06	3.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—rheumatoid arthritis	8.22e-06	3.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TYK2—rheumatoid arthritis	8.16e-06	3.7e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.14e-06	3.69e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—rheumatoid arthritis	8.13e-06	3.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2RA—rheumatoid arthritis	8.11e-06	3.67e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	8.08e-06	3.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—rheumatoid arthritis	8.04e-06	3.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—C3—rheumatoid arthritis	8.04e-06	3.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—rheumatoid arthritis	8e-06	3.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—rheumatoid arthritis	7.99e-06	3.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.98e-06	3.62e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	7.92e-06	3.59e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAT—rheumatoid arthritis	7.7e-06	3.49e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—rheumatoid arthritis	7.67e-06	3.48e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.55e-06	3.42e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—rheumatoid arthritis	7.55e-06	3.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEP—rheumatoid arthritis	7.48e-06	3.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—rheumatoid arthritis	7.42e-06	3.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—rheumatoid arthritis	7.38e-06	3.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—rheumatoid arthritis	7.38e-06	3.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	7.37e-06	3.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	7.37e-06	3.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—rheumatoid arthritis	7.35e-06	3.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—rheumatoid arthritis	7.32e-06	3.32e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.12e-06	3.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FN1—rheumatoid arthritis	7.06e-06	3.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6ST—rheumatoid arthritis	7.03e-06	3.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NFKB1—rheumatoid arthritis	6.88e-06	3.12e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK8—rheumatoid arthritis	6.77e-06	3.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CD80—rheumatoid arthritis	6.77e-06	3.07e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAT—rheumatoid arthritis	6.67e-06	3.02e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	6.63e-06	3.01e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	6.43e-06	2.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—POMC—rheumatoid arthritis	6.43e-06	2.91e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—rheumatoid arthritis	6.31e-06	2.86e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL2—rheumatoid arthritis	6.29e-06	2.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6R—rheumatoid arthritis	6.27e-06	2.84e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—rheumatoid arthritis	6.22e-06	2.82e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	6.1e-06	2.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAT—rheumatoid arthritis	5.96e-06	2.7e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAT—rheumatoid arthritis	5.81e-06	2.64e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—rheumatoid arthritis	5.78e-06	2.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TYK2—rheumatoid arthritis	5.71e-06	2.59e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—rheumatoid arthritis	5.69e-06	2.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—rheumatoid arthritis	5.61e-06	2.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	5.57e-06	2.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—rheumatoid arthritis	5.29e-06	2.4e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—POMC—rheumatoid arthritis	5.14e-06	2.33e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	4.98e-06	2.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—rheumatoid arthritis	4.97e-06	2.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	4.97e-06	2.25e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	4.85e-06	2.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—rheumatoid arthritis	4.75e-06	2.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—rheumatoid arthritis	4.73e-06	2.14e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—rheumatoid arthritis	4.69e-06	2.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—rheumatoid arthritis	4.5e-06	2.04e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	4.48e-06	2.03e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—POMC—rheumatoid arthritis	4.45e-06	2.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NFKB1—rheumatoid arthritis	4.45e-06	2.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK8—rheumatoid arthritis	4.37e-06	1.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—rheumatoid arthritis	4.32e-06	1.96e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	4.1e-06	1.86e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—rheumatoid arthritis	4.06e-06	1.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—rheumatoid arthritis	4.04e-06	1.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—rheumatoid arthritis	3.99e-06	1.81e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—POMC—rheumatoid arthritis	3.98e-06	1.8e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	3.88e-06	1.76e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—POMC—rheumatoid arthritis	3.88e-06	1.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—rheumatoid arthritis	3.71e-06	1.68e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—rheumatoid arthritis	3.62e-06	1.64e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	3.58e-06	1.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	3.55e-06	1.61e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.54e-06	1.6e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	3.47e-06	1.57e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	3.38e-06	1.53e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	3.17e-06	1.44e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	3.09e-06	1.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—rheumatoid arthritis	3.05e-06	1.38e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.99e-06	1.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—rheumatoid arthritis	2.79e-06	1.27e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.39e-06	1.08e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.18e-06	9.88e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.08e-06	9.45e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.91e-06	8.64e-06	CbGpPWpGaD
